The TGA has joined an international campaign to combat antimicrobial resistance
The organisation has now joined the International Coalition of Medicines Regulatory Authorities, an international alliance of the leaders of medicines regulatory agencies that addresses global regulatory challenges, and the World Health Organisation in the effort.
The TGA is the Vice-Chair of ICMRA and leads the pharmacovigilance working group.
It is currently World Antibiotic Awareness Week (18-24 November 2019) and ICMRA members are raising awareness of the growing public health problem of AMR through coordinated communication activities, such as letters to stakeholders and social media.
“The WHO has declared AMR, which includes resistance to antibiotics, to be one of the top ten threats to global public health,” says the TGA.
“Antimicrobial-resistant infections are becoming more frequent and increasingly difficult to treat. Left unchecked, many treatable infections could become untreatable.
“Without action, it is estimated that AMR could be the cause of 10 million deaths each year, as well as an annual loss of economic output of USD $100 trillion by 2050.
“The TGA and ICMRA call for the global community to preserve the antimicrobials currently available, and to promote the development of innovative new diagnostics and treatments.”
The TGA listed ways in which non-regulatory stakeholders can help: including health professionals.
“Healthcare practitioners (human and animal health) can prioritise appropriate use of antimicrobials and incorporate responsible antimicrobial prescribing principles into clinical practice,” it says.
“ICMRA has sent official letters to key international stakeholders urging them to join this global effort.
“These stakeholders include G7/G20, OECD, UN, World Bank, WHO, public/private partnerships such as CARB-x and Drive-AB, and regional and international harmonisation initiatives.
“We all have a responsibility to combat antimicrobial resistance. Through ICMRA, the TGA will explore ways to work with stakeholders to find safe, effective, and innovative solutions to the challenges of AMR.”